Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA
Qiongyu Hao(UCLA Jonsson Comprehensive Cancer Center), Yong Wu(UCLA Jonsson Comprehensive Cancer Center)
Cited by 19
Related Papers
Tumor-Derived Exosomes in Tumor-Induced Immune Suppression
|International Journal of Molecular Sciences|2022|71